Substance Use Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

The 7 major substance use disorder markets reached a value of US$ 5.1 Million in 2023. Looking forward, the publisher expects the 7MM to reach US$ 7.5 Million by 2034, exhibiting a growth rate (CAGR) of 4.38% during 2023-2034.

The substance use disorder market has been comprehensively analyzed in this report titled "Substance Use Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Substance use disorder (SUD) refers to a chronic, relapsing medical condition that is characterized by compulsive drug or alcohol usage. It can have a significant impact on an individual's physical and mental health, relationships, work, and overall quality of life. Substance use disorder can develop through recreational drug use or by prolonged consumption of prescribed medications, such as painkillers. Symptoms of the condition can vary depending on the substance used, the frequency and amount of use, and the individual's medical and personal history. Some of the common symptoms of SUD are strong urges to consume drugs or alcohol, continued substance use despite negative consequences, withdrawal signs like anxiety, agitation, insomnia, physical symptoms like nausea and sweating, etc. Other indications include social, legal, and financial problems, strained relationships with family and friends, etc. Diagnosis of SUD usually involves a thorough evaluation by a healthcare professional, including medical history, physical examination, and behavioral assessment.

The rising usage of prescription/illicit drugs coupled with the increasing consumption of tobacco and alcohol is primarily driving the global substance use disorder market. In addition to this, the emerging popularity of outpatient rehabilitation programs, which allow individuals to live at home while receiving regular treatment, such as therapy or medication-assisted treatment (MAT), is further creating a positive outlook for the market. Moreover, several government bodies across the globe are taking initiatives to create awareness and understanding of SUD as a treatable medical condition, thus reducing the stigma associated with it and encouraging more people to seek treatment. This, in turn, is acting as a significant growth-inducing factor. Apart from this, the introduction of private insurance coverage for substance abuse disorder treatment, which has made it easier for individuals to access and afford the medicament, is also propelling the global market. Additionally, the escalating utilization of holistic therapeutic approaches, such as yoga, meditation, acupuncture, etc., in combination with traditional SUD treatments to address the physical, emotional, and spiritual aspects of substance abuse is further bolstering the market growth. Besides this, the widespread adoption of behavioral therapies, including cognitive-behavioral therapy (CBT) and motivational interviewing, which help in identifying and changing negative thought patterns and behaviors related to substance abuse, is expected to drive the global substance use disorder market during the forecast period.

This report provides an exhaustive analysis of the substance use disorder market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario and unmet medical needs, etc. have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the substance use disorder market in any manner.

Time Period of the Study

• Base Year: 2023
• Historical Period: 2018-2023
• Market Forecast: 2024-2034

Countries Covered

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan

Analysis Covered Across Each Country

• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the substance use disorder market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the substance use disorder market

Competitive Landscape:

This report also provides a detailed analysis of the current substance use disorder marketed drugs and late-stage pipeline drugs.

In-Market Drugs

• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance

*Kindly note that the drugs in the above table only represent a partial list of marketed/pipeline drugs, and the complete list has been provided in the report.

Key Questions Answered in this Report:

Market Insights

• How has the substance use disorder market performed so far and how will it perform in the coming years?
• What are the markets shares of various therapeutic segments in 2023 and how are they expected to perform till 2034?
• What was the country-wise size of the substance use disorder market across the seven major markets in 2023 and what will it look like in 2034?
• What is the growth rate of the substance use disorder market across the seven major markets and what will be the expected growth over the next ten years?
• What are the key unmet needs in the market?

Epidemiology Insights

• What is the number of prevalent cases (2018-2034) of substance use disorder across the seven major markets?
• What is the number of prevalent cases (2018-2034) of substance use disorder by age across the seven major markets?
• What is the number of prevalent cases (2018-2034) of substance use disorder by gender across the seven major markets?
• What is the number of prevalent cases (2018-2034) of substance use disorder by type across the seven major markets?
• How many patients are diagnosed (2018-2034) with substance use disorder across the seven major markets?
• What is the size of the substance use disorder patient pool (2018-2023) across the seven major markets?
• What would be the forecasted patient pool (2024-2034) across the seven major markets?
• What are the key factors driving the epidemiological trend of substance use disorder?
• What will be the growth rate of patients across the seven major markets?

Substance Use Disorder: Current Treatment Scenario, Marketed Drugs and Emerging Therapies

• What are the current marketed drugs and what are their market performance?
• What are the key pipeline drugs and how are they expected to perform in the coming years?
• How safe are the current marketed drugs and what are their efficacies?
• How safe are the late-stage pipeline drugs and what are their efficacies?
• What are the current treatment guidelines for substance use disorder drugs across the seven major markets?
• Who are the key companies in the market and what are their market shares?
• What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the substance use disorder market?
• What are the key regulatory events related to the substance use disorder market?
• What is the structure of clinical trial landscape by status related to the substance use disorder market?
• What is the structure of clinical trial landscape by phase related to the substance use disorder market?
• What is the structure of clinical trial landscape by route of administration related to the substance use disorder market?

This product will be updated with the latest data at the time of order. Consequently, dispatch time for this product will be 7-10 business days.